&Partners’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Buy
289,127
+120,061
+71% +$4.75M 0.05% 333
2026
Q1
$6.02M Buy
169,066
+148,507
+722% +$5.56M 0.03% 472
2025
Q4
$786K Buy
20,559
+5,348
+35% +$205K ﹤0.01% 1357
2025
Q3
$573K Buy
15,211
+457
+3% +$16.7K ﹤0.01% 1374
2025
Q2
$521K Buy
14,754
+1,580
+12% +$51.8K ﹤0.01% 1336
2025
Q1
$424K Buy
13,174
+5,804
+79% +$195K ﹤0.01% 1213
2024
Q4
$247K Buy
+7,370
New +$248K ﹤0.01% 1436

Other funds holding TCAF

&Partners's TCAF Position: Q2 2026 in Review

&Partners increased its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 71% in Q2 2026, buying an estimated $4.75M and bringing the position to 289,127 shares worth $11.9M. The position accounts for 0.05% of the portfolio, ranked #333.

&Partners first reported a position in TCAF in Q4 2024 and has held it in 7 quarters since. 357 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

  • &Partners held 289,127 shares of T. Rowe Price Capital Appreciation Equity ETF worth $11.9M as of Q2 2026.
  • &Partners bought 120,061 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $4.75M.
  • T. Rowe Price Capital Appreciation Equity ETF made up 0.05% of &Partners's portfolio in Q2 2026, its #333 holding.
  • &Partners first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q4 2024 and has held it in 7 quarters since.
  • 357 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.